Simona Lamba

7.4k total citations · 2 hit papers
39 papers, 3.3k citations indexed

About

Simona Lamba is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Simona Lamba has authored 39 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Oncology and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Simona Lamba's work include Colorectal Cancer Treatments and Studies (14 papers), Genetic factors in colorectal cancer (9 papers) and Cancer Genomics and Diagnostics (9 papers). Simona Lamba is often cited by papers focused on Colorectal Cancer Treatments and Studies (14 papers), Genetic factors in colorectal cancer (9 papers) and Cancer Genomics and Diagnostics (9 papers). Simona Lamba collaborates with scholars based in Italy, Netherlands and United States. Simona Lamba's co-authors include Alberto Bardelli, Federica Di Nicolantonio, Fonnet E. Bleeker, Milo Frattini, Salvatore Siena, Andrea Sartore‐Bianchi, Sabrina Arena, Sieger Leenstra, W. Peter Vandertop and Aldo Scarpa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Nature Communications.

In The Last Decade

Simona Lamba

39 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab

2010 573 citations Federica Di Nicolantonio, Andrea Sartore‐Bianchi et al. profile →
High-dose vitamin C enhances cancer immunotherapy

2020 199 citations Alessandro Magrì, Giovanni Germano et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simona Lamba Italy	25	1.5k	1.5k	1.0k	760	713	39	3.3k
Oleg Schmidt‐Kittler United States	18	1.5k 1.0×	2.1k 1.4×	1.2k 1.1×	525 0.7×	325 0.5×	24	3.5k
Mark R. Lackner United States	32	1.8k 1.2×	2.6k 1.7×	1.5k 1.5×	988 1.3×	449 0.6×	82	4.4k
Natalie Silliman United States	13	1.8k 1.2×	3.6k 2.4×	1.3k 1.3×	919 1.2×	943 1.3×	17	5.1k
Sauveur-Michel Maira Switzerland	31	1.4k 0.9×	3.5k 2.3×	778 0.8×	821 1.1×	506 0.7×	42	4.7k
Nina N. Nupponen Finland	35	999 0.7×	2.2k 1.5×	1.1k 1.1×	1.4k 1.9×	507 0.7×	64	4.5k
Mónica Arnedos France	25	1.6k 1.1×	1.4k 0.9×	1.2k 1.2×	1.0k 1.3×	293 0.4×	90	3.1k
Nathalie Cervera France	25	2.1k 1.4×	2.3k 1.5×	1.6k 1.6×	400 0.5×	300 0.4×	32	4.2k
Diana Mandelker United States	23	867 0.6×	1.3k 0.9×	718 0.7×	482 0.6×	388 0.5×	94	2.5k
Judy Dering United States	23	2.2k 1.5×	1.5k 1.0×	902 0.9×	1.3k 1.7×	225 0.3×	41	3.6k
Pieter J.A. Eichhorn Singapore	25	1.3k 0.9×	2.7k 1.8×	682 0.7×	525 0.7×	288 0.4×	34	3.6k

Countries citing papers authored by Simona Lamba

Since Specialization

Citations

This map shows the geographic impact of Simona Lamba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simona Lamba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simona Lamba more than expected).

Fields of papers citing papers by Simona Lamba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simona Lamba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simona Lamba. The network helps show where Simona Lamba may publish in the future.

Co-authorship network of co-authors of Simona Lamba

This figure shows the co-authorship network connecting the top 25 collaborators of Simona Lamba. A scholar is included among the top collaborators of Simona Lamba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simona Lamba. Simona Lamba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maione, Federica, Daniele Oddo, Chiara Falcomatà, et al.. (2024). Preclinical efficacy of carfilzomib in BRAF ‐mutant colorectal cancer models. Molecular Oncology. 18(6). 1552–1570. 4 indexed citations

Rospo, Giuseppe, Rosaria Chilà, Vittoria Matafora, et al.. (2024). Non-canonical antigens are the largest fraction of peptides presented by MHC class I in mismatch repair deficient murine colorectal cancer. Genome Medicine. 16(1). 15–15. 11 indexed citations

Amodio, Vito, Simona Lamba, Rosaria Chilà, et al.. (2022). Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance. Cancer Cell. 41(1). 196–209.e5. 24 indexed citations

Russo, Mariangela, Simone Pompei, Alberto Sogari, et al.. (2022). A modified fluctuation-test framework characterizes the population dynamics and mutation rate of colorectal cancer persister cells. Nature Genetics. 54(7). 976–984. 32 indexed citations

Magrì, Alessandro, Giovanni Germano, Annalisa Lorenzato, et al.. (2020). High-dose vitamin C enhances cancer immunotherapy. Science Translational Medicine. 12(532). 199 indexed citations breakdown →

Bartolini, Alice, Simona Lamba, Daniele Oddo, et al.. (2016). BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS-Mutant Colorectal Cancer. Clinical Cancer Research. 22(19). 4923–4933. 51 indexed citations

Maione, Federica, Mélissande Cossutta, Gilles Carpentier, et al.. (2016). Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature. Cancer Research. 76(24). 7181–7193. 100 indexed citations

Médico, Enzo, Mariangela Russo, Gabriele Picco, et al.. (2015). The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets. Nature Communications. 6(1). 7002–7002. 217 indexed citations

Molenaar, Remco J., Dagmar Verbaan, Simona Lamba, et al.. (2014). The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone. Neuro-Oncology. 16(9). 1263–1273. 158 indexed citations

10.

Bleeker, Fonnet E., Simona Lamba, Carlo Zanon, et al.. (2014). Mutational profiling of kinases in glioblastoma. BMC Cancer. 14(1). 718–718. 50 indexed citations

11.

Lamba, Simona, Mariangela Russo, Chong Sun, et al.. (2014). RAF Suppression Synergizes with MEK Inhibition in KRAS Mutant Cancer Cells. Cell Reports. 8(5). 1475–1483. 87 indexed citations

12.

Martini, Miriam, Mariangela Russo, Simona Lamba, et al.. (2013). Mixed Lineage Kinase MLK4 Is Activated in Colorectal Cancers Where It Synergistically Cooperates with Activated RAS Signaling in Driving Tumorigenesis. Cancer Research. 73(6). 1912–1921. 16 indexed citations

13.

Sartore‐Bianchi, Andrea, Katia Bencardino, Federica Di Nicolantonio, et al.. (2010). Integrated molecular dissection of the epidermal growth factor receptor (EFGR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer. Targeted Oncology. 5(1). 19–28. 25 indexed citations

14.

Barbi, Stefano, Ivana Cataldo, Giovanni De Manzoni, et al.. (2010). The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type. Journal of Experimental & Clinical Cancer Research. 29(1). 32–32. 56 indexed citations

15.

Bleeker, Fonnet E., Simona Lamba, Carlo Zanon, et al.. (2009). Absence of AKT1 Mutations in Glioblastoma. PLoS ONE. 4(5). e5638–e5638. 27 indexed citations

16.

Lamba, Simona, Lara Felicioni, Fiamma Buttitta, et al.. (2009). Mutational Profile of GNAQQ209 in Human Tumors. PLoS ONE. 4(8). e6833–e6833. 60 indexed citations

17.

Sartore‐Bianchi, Andrea, Federica Di Nicolantonio, Michele Nichelatti, et al.. (2009). Multi-Determinants Analysis of Molecular Alterations for Predicting Clinical Benefit to EGFR-Targeted Monoclonal Antibodies in Colorectal Cancer. PLoS ONE. 4(10). e7287–e7287. 219 indexed citations

18.

Bleeker, Fonnet E., Simona Lamba, Sieger Leenstra, et al.. (2009). IDH1mutations at residue p.R132 (IDH1^R132) occur frequently in high-grade gliomas but not in other solid tumors. Human Mutation. 30(1). 7–11. 300 indexed citations

19.

Buttitta, Fiamma, Simona Lamba, Luca Cardone, et al.. (2008). AKT1E17K in human solid tumours. Oncogene. 27(42). 5648–5650. 175 indexed citations

20.

Balakrishnan, Asha, Fonnet E. Bleeker, Simona Lamba, et al.. (2007). Novel Somatic and Germline Mutations in Cancer Candidate Genes in Glioblastoma, Melanoma, and Pancreatic Carcinoma. Cancer Research. 67(8). 3545–3550. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact